Immune status following alemtuzumab treatment in human CD52 transgenic mice
暂无分享,去创建一个
J. Kaplan | B. Roberts | N. Chrétien | E. Havari | W. Siders | Michael J. Lamorte | M. J. Turner | M. Turner
暂无分享,去创建一个
J. Kaplan | B. Roberts | N. Chrétien | E. Havari | W. Siders | Michael J. Lamorte | M. J. Turner | M. Turner